Stock Research: Almirall

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Almirall

BME:ALM ES0157097017
88
  • Value
    56
  • Growth
    95
  • Safety
    Safety
    60
  • Combined
    90
  • Sentiment
    54
  • 360° View
    360° View
    88
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Almirall SA is a pharmaceutical company focused on developing and marketing drugs for various therapeutic areas. The company operates in pharmaceuticals, including nervous system, gastrointestinal, dermatological, respiratory system, and antiinfectives. It operates in Europe, the Americas, Africa, Asia, and Australia. In the last fiscal year, the company had a market cap of $2,641 million, profits of $795 million, and revenue of $1,021 million with 2026 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 88 (better than 88% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Almirall are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Almirall. The consolidated Value Rank has an attractive rank of 60, which means that the share price of Almirall is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 60% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 95, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 56. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 54. ...read more

more
Index
IBEX 35
Sound Pay Europe
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
60 72 67 72
Growth
95 24 27 41
Safety
Safety
56 56 68 70
Sentiment
54 65 54 54
360° View
360° View
88 54 59 72
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
76 78 53 69
Opinions Change
41 26 63 50
Pro Holdings
n/a 46 24 22
Market Pulse
64 83 71 65
Sentiment
54 65 54 54
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
60 72 67 72
Growth
95 24 27 41
Safety Safety
56 56 68 70
Combined
90 61 60 63
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
20 32 22 37
Price vs. Earnings (P/E)
63 67 69 83
Price vs. Book (P/B)
66 80 88 83
Dividend Yield
52 51 55 57
Value
60 72 67 72
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
81 83 56 37
Profit Growth
100 10 33 39
Capital Growth
45 4 16 71
Stock Returns
85 53 46 42
Growth
95 24 27 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
62 63 56 45
Refinancing
65 67 79 80
Liquidity
32 35 36 41
Safety Safety
56 56 68 70

Similar Stocks

Discover high‑ranked alternatives to Almirall and broaden your portfolio horizons.

Ipsen

ENXTPA:IPN
Country: France
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

SSE

LSE:SSE
Country: United Kingdom
Industry: Electric Utilities
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.